|
|
|
[unknown placeholder $cat.num$] Last Updated: Mar 19, 2007 - 3:12:58 AM |
Non-Public Companies
:
Healthcare/BioTech
Two OR-Live Surgical Webcasts Nominated for Best Events and Live Broadcasts for the 12th Annual Webby Awards
WEST HARTFORD, CT -- (MARKET WIRE) -- 04/11/08 -- The 12th Annual Webby Awards Committeehas announced that it has nominated two of OR-Live's programs for the BestEvents and Live Broadcasts of 2007. The two webcasts are Breast Cancer:Reconstruction Immediately Following Radical Mastectomy from ThomasJefferson University Hospital, originally broadcast October 18, 2007,and Heart TransplantProcedure From Montefiore-Einstein Heart Center, originally broadcaston September 19, 2007. A total of five programs were nominated in thecategory and OR-Live is the only company that has two entries being considered forthe Award. The Webby Awards received over 10,000 entries.
Apr 11, 2008 - 11:36:03 AM
Non-Public Companies
:
Healthcare/BioTech
Hyperbaric Chamber at Presbyterian Hospital of Dallas Reaches Milestone, Stands at Forefront of 'Atmospheric' Medicine
DALLAS, TX -- (MARKET WIRE) -- 04/11/08 -- When the Hyperbaric Medicine Unit at Presbyterian Hospital of Dallas opened 15 yearsago, it was one of the only units of its kind in the region. Originallyused to treat decompression illness in SCUBA divers and carbon monoxidepoisoning, the science of hyperbaric medicine slowly expanded asresearchers theorized it could treat other ailments.
Apr 11, 2008 - 11:36:03 AM
Non-Public Companies
:
Healthcare/BioTech
Gen Re Expands Presence in China With Partnership With VHS
SHANGHAI, CHINA -- (MARKET WIRE) -- 04/10/08 -- Valurise Health Solutions ("VHS"), thepioneer in health management services in China, and Cologne ReinsuranceCompany ("Gen Re"), one of the largest international reinsurers, todayannounced a partnership between VHS and Gen Re to jointly expand Chronicdisease prevention and health management initiatives in China insuranceindustry and to provide support to insurers in domains of health insuranceproducts development and health insurance risk management in China.
Apr 10, 2008 - 10:36:02 PM
Non-Public Companies
:
Healthcare/BioTech
Sonitor Technologies(R) to Showcase New Proprietary Ultrasound Identification RTLS (USID) Platform at RFID Journal Live!
LARGO, FL -- (MARKET WIRE) -- 04/10/08 -- Sonitor Technologies, Inc. today announced thatthe Company is scheduled to exhibit its latest ultrasound identification(USID) products at the 6th Annual RFID Journal Live!, to be held from April16-18, 2008 in Las Vegas.
Apr 10, 2008 - 8:36:01 AM
Non-Public Companies
:
Healthcare/BioTech
Proactive Planning Opens the Door to Effective Lifecycle Management
RESEARCH TRIANGLE PARK, NC -- (MARKET WIRE) -- 04/10/08 -- According to a new studyreleased by Cutting Edge Information, the most successful lifecyclemanagement (LCM) programs are those that begin planning at the start of adrug's development. The report, "Pharma Brand Optimization: LifecycleManagement Strategy," explores the value of proactive planning(http://www.PharmaLifecycleManagement.com).
Apr 10, 2008 - 8:36:01 AM
Non-Public Companies
:
Healthcare/BioTech
REMINDER: ORLive Presents: Pediatric Grand Rounds Lecture Entitled Mechanical Support for a Child's Failing Heart: Past, Present and Future
PITTSBURGH, PA -- (MARKET WIRE) -- 04/10/08 -- Pediatric patients with severe cardiacdysfunction can benefit from the placement of a ventricular assist device.Unfortunately, the availability of pediatric mechanical devices is verylimited, especially for the management of neonates, infants and smallchildren.
Apr 10, 2008 - 6:36:01 AM
Non-Public Companies
:
Healthcare/BioTech
Life Science Industry Dominates New England's 2007 New Plant Start-Ups, an Industrial Info News Alert
SUGAR LAND, TX -- (MARKET WIRE) -- 04/10/08 -- Reported by Annette Kreuger, Industrial InfoResources (Sugar Land, Texas) -- The New England region has long been apreferred site for the life science industry. Its top-notch universitiesand strong research infrastructure help to ensure the region a spot withmost industry site-selection committees. Underscoring this pattern ofsuccess in attracting Pharmaceutical & Biotech capital dollars is that outof the 14 new facilities that opened in 2007, nine of them, or 64%, werefor either medical/drug research and/or drug production.
Apr 10, 2008 - 5:36:01 AM
Non-Public Companies
:
Healthcare/BioTech
SRI International to Present SERM Case Study at the American Association for Cancer Research Annual Meeting
MENLO PARK, CA -- (MARKET WIRE) -- 04/09/08 -- SRI International, an independent, nonprofitscientific research institute, announced today that a case study onsuccessfully converting an effective molecule into an approved drug will bepresented at the American Association for Cancer Research (AACR) AnnualMeeting 2008, to be held April 12-16 in San Diego, California.
Apr 9, 2008 - 10:36:01 AM
Non-Public Companies
:
Healthcare/BioTech
North American Pharma-Bio Industry's $20 Billion Capital Investment Mapped Out, an Industrial Info News Alert
SUGAR LAND, TX -- (MARKET WIRE) -- 04/09/08 -- Reported by Annette Kreuger, Industrial InfoResources (Sugar Land, Texas) -- In North America, the Pharmaceutical &Biotech Industry is currently forecast to begin construction on more than$20 billion worth of capital and maintenance (MRO) projects in 2008.Spread over 569 individual projects, the average total investment value(TIV) translates into $35 million. Every major market region willexperience some of this activity, according to a recent analysis of activeprojects. To better illustrate the impact of this essential industry,Industrial Info has just released the 2008 Market Outlook of the Pharmaceutical & BiotechIndustry, the latest offering in Industrial Info's North AmericanIndustrial Market Map series.
Apr 9, 2008 - 7:36:02 AM
Non-Public Companies
:
Healthcare/BioTech
REMINDER: ORLive Presents: Hybrid Maze Minimally Invasive Approach to Treat Atrial Fibrillation
CHICAGO, IL -- (MARKET WIRE) -- 04/09/08 -- Richard Lee, MD, cardiac surgeon and surgicaldirector for the Center of Atrial Fibrillation at the Bluhm CardiovascularInstitute of Northwestern Memorial Hospital is pioneering the Hybrid Mazeprocedure, a minimally invasive surgery for patients with atrialfibrillation.
Apr 9, 2008 - 6:36:01 AM
Non-Public Companies
:
Healthcare/BioTech
New Study Analyzes Medical Science Liaisons' Programs, Finds Function's Strategic Influence Increasing
RESEARCH TRIANGLE PARK, NC -- (MARKET WIRE) -- 04/09/08 -- Medical science liaisons'strategic importance is on the rise, according to a new report frompharmaceutical business intelligence leader Cutting Edge Information.
Apr 9, 2008 - 6:36:01 AM
Non-Public Companies
:
Healthcare/BioTech
Actavis acquires API manufacturing company in China
REYKJAVIK, ICELAND -- (MARKET WIRE) -- 04/09/08 -- Reykjavik, Iceland, 9 April 2008 --Actavis Group, the internationalgeneric pharmaceuticals company, today announced that it has acquireda 90% share in Zhejiang Chiral Medicine Chemicals Company for anundisclosed amount.
Apr 9, 2008 - 5:36:01 AM
Non-Public Companies
:
Healthcare/BioTech
Allegretto Wave System Expands the Boundaries of Candidacy for Lasik
HOUSTON, TX -- (MARKET WIRE) -- 04/08/08 -- As a result of eight years of experience withthe Allegretto Excimer Laser Systems, doctors at the International EyeCareLaser Center in Houston have found a dramatic increase in the number ofcandidates eligible for lasik surgery.
Apr 8, 2008 - 9:36:01 PM
Non-Public Companies
:
Healthcare/BioTech
BRAHMS Receives FDA Clearance to Market Automated Procalcitonin (PCT) Test
ANNAPOLIS, MD -- (MARKET WIRE) -- 04/08/08 -- BRAHMS USA, Inc. today announced it hasreceived 510(k) clearance from the U.S. Food and Drug Administration (FDA)to market its patented Procalcitonin (PCT) Kryptor® test. The automatedtest will be used in critically ill patients on the first day of ICUadmission as an aid to assess their risk for progression to severe sepsisand septic shock.
Apr 8, 2008 - 3:36:01 PM
Non-Public Companies
:
Healthcare/BioTech
Adults Who Eat Apples, Drink Apple Juice Have Lower Risk for Metabolic Syndrome
SAN DIEGO, CA -- (MARKET WIRE) -- 04/08/08 -- Not eating your apple a day? Perhaps youshould be. Adults who eat apples, apple juice and applesauce have asignificantly reduced risk of metabolic syndrome, a cluster of healthproblems that are linked to numerous chronic diseases such as diabetes andcardiovascular disease.
Apr 8, 2008 - 1:36:01 PM
Non-Public Companies
:
Healthcare/BioTech
Scandinavian Clinical Nutrition to Become World Leader Within Diagnosis and Research in the Field of Virus-Induced Obesity
STOCKHOLM, SWEDEN -- (MARKET WIRE) -- 04/08/08 -- Scandinavian Clinical Nutrition(SCN) (Ticker: SCN) signed a world-wide license agreement for thepatent rights to the obesity related virus adenovirus 36 (AD36). Theagreement is signed between SCN and the internationally renowned researcherand professor RichardL. Atkinson. In conjunction with the agreement, SCN has initiatedadditional research cooperation with Karolinska Institutet in Stockholm,one of Europe's leading medical universities, and Professor Atkinson. SCNaims for a commercial launch of its first diagnostic tests within six totwelve months.
Apr 8, 2008 - 12:36:01 PM
Non-Public Companies
:
Healthcare/BioTech
ORLive Presents: Virtually Scrub in With Gerald Williams, MD, to Perform Global(TM) AP(R) Shoulder Procedure
WARSAW, IN -- (MARKET WIRE) -- 04/08/08 -- On April 17, 2008, at 4:00 p.m. Eastern Time,surgeons and others are welcome to virtually scrub in with Gerald Williams,MD, to perform a shoulder replacement with the Global(TM) AP®Shoulder System from DePuy Orthopaedics, Inc. atMethodist Hospital in Philadelphia, Pennsylvania. DePuy Orthopaedics' ismaking the broadcast available for free via www.OR-Live.com.
Apr 8, 2008 - 10:36:01 AM
Non-Public Companies
:
Healthcare/BioTech
Compliance Departments Take Active Role in Training, According to New Cutting Edge Information Study
RESEARCH TRIANGLE PARK, NC -- (MARKET WIRE) -- 04/08/08 -- Compliance departments atpharmaceutical companies are taking a proactive approach to trainingemployees company-wide to ensure that they meet industry regulations andguidelines, a new report by Cutting Edge Information finds. The study,"Monitoring and Ensuring Pharmaceutical Compliance," reveals that 81% ofpharmaceutical compliance groups conduct training for other departmentswithin the company.
Apr 8, 2008 - 6:36:01 AM
Non-Public Companies
:
Healthcare/BioTech
Collatamp(TM) EG Receives Marketing Authorization in Brazil
CHARLOTTE, NC -- (MARKET WIRE) -- 04/07/08 -- BurnsAdler Pharmaceuticals, Inc.("BurnsAdler") announced today that Collatamp(TM) EG has received marketingapproval from ANVISA - National Agency for Surveillance in Brazil.Collatamp(TM) EG is a fully resorbable Gentamicin-impregnated CollagenSponge, used as a surgical implant for local haemostasis of capillary,parenchymatous and seeping hemorrhages in areas with a high risk ofinfection. BurnsAdler will be co-marketing Collatamp(TM) EG with its localpartner Meizler Biopharma, S.A. ("Meizler").
Apr 7, 2008 - 5:36:02 PM
Non-Public Companies
:
Healthcare/BioTech
New Catholic Healthcare West Ad Campaign Urges America to Put the 'Care' Back in Health Care
SAN FRANCISCO, CA -- (MARKET WIRE) -- 04/07/08 -- Catholic Healthcare West (CHW) todaylaunched a new advertising campaign aimed at provoking a robust publicdiscussion of health care reform, medical costs and the environment.
Apr 7, 2008 - 2:36:01 PM
Non-Public Companies
:
Healthcare/BioTech
MEDIA ADVISORY: Editors, Reporters Welcome to Hear Linda Armstrong Kelly and Shelley Morrison Speak on Tireless Efforts to Support Cancer Survival at PDA Annual Meeting
BETHESDA, MD -- (MARKET WIRE) -- 04/07/08 -- Linda Armstrong Kelly and Shelley Morrisonwill explore their stories of survival and tireless efforts to make thepublic, government and industry aware of the need to support furtherdevelopment and distribution of innovative and efficacious drugs to treatcancer on April 14 at the PDA 2008 Annual Meeting in Colorado Springs,Colorado.
Apr 7, 2008 - 8:36:02 AM
Non-Public Companies
:
Healthcare/BioTech
Autism Treatment Center of America CEO, Himself Fully Recovered From Autism, Unleashes Part 4 of Bold 7-Part Challenge for Autism Awareness Month -- Stop Calling Our Children Tragic
SHEFFIELD, MA -- (MARKET WIRE) -- 04/07/08 -- Raun K. Kaufman, CEO of The Autism TreatmentCenter of America (www.autismtreatmentcenter.org), continues unveiling hisradical seven-part plan to help children with autism:
Apr 7, 2008 - 8:36:01 AM
Non-Public Companies
:
Healthcare/BioTech
The GI Company to Present Phase I & II Oral Mucositis Data at MASCC / ISOO Annual Meeting
FRAMINGHAM, MA -- (MARKET WIRE) -- 04/07/08 -- The GI Company, Inc., a privately helddeveloper of gastrointestinal therapeutics, today announced that anabstract detailing combined results from its Phase I and Phase II clinicaltrials has been accepted for a poster presentation at the MultinationalAssociation of Supportive Care in Cancer's and the International Society ofOral Oncology's 2008 International Symposium on Supportive Care in Cancer(MASCC / ISOO). The symposium takes place June 26-28, 2008 at the HiltonHotel Houston, Texas.
Apr 7, 2008 - 7:36:04 AM
Non-Public Companies
:
Healthcare/BioTech
Novartis to further strengthen its healthcare portfolio by acquiring 25% stake in Alcon from Nestlé with right to take over majority ownership of the world leader in eye care
BASEL, SWITZERLAND -- (MARKET WIRE) -- 04/07/08 --
Apr 7, 2008 - 1:36:02 AM
Non-Public Companies
:
Healthcare/BioTech
Kinexum Metabolics, Inc. Announces Abstracts on INGAP Peptide Will Be Presented at Keystone Symposia
WASHINGTON, DC -- (MARKET WIRE) -- 04/04/08 -- Kinexum Metabolics, Inc. (KMI) announced twoabstracts will be presented on INGAP Peptide at the Keystone Symposia onIslet and Beta Cell Biology to be held April 6-10, 2008. These two studiesdemonstrate important new data to advance the development of INGAP Peptideas a treatment to regenerate fully functioning islet cells that can restoreinsulin secretion for Type 1 diabetes patients. "We are encouraged bythese new studies and believe they demonstrate great potential for INGAPPeptide as a therapeutic approach for Type 1 diabetes and insulin-dependentType 2 diabetes," stated Dr. Alexander Fleming, founder and Chief MedicalOfficer of KMI and a well-known authority on metabolic drug development."These new data demonstrate for the first time induction of endocrine cellsfrom a human pancreatic ductal cell line in vitro and the use ofcombination therapy to induce islet regeneration and clinical remission ina model of established (not new onset) T1 diabetes."
Apr 4, 2008 - 2:36:03 PM
Non-Public Companies
:
Healthcare/BioTech
Pharmacy Benefits Industry Consolidation Pushes Plan Sponsors to Seek More Choices and Flexibility in PBM Contracts
ST. PAUL, MN -- (MARKET WIRE) -- 04/03/08 -- As CVS Caremark celebrates the firstanniversary of the merger that brought together retail pharmacy giant CVSCorp. and pharmacy benefit manager Caremark Rx, others in the pharmacybenefits industry are taking time to reflect on the significance of thetrend toward consolidation.
Apr 3, 2008 - 3:36:01 PM
Non-Public Companies
:
Healthcare/BioTech
Smiles for Miles: First 5 California Mobile Tour Partners With Dr. Fresh
SACRAMENTO, CA -- (MARKET WIRE) -- 04/03/08 -- First 5California today announced the launch of its partnership withCalifornia-based dental product manufacturer Dr. Fresh to promote healthydental care among California's youngest children. Through the partnership,Dr. Fresh will provide a free FireFly toothbrush to each family visitingFirst 5 California's Hands-on Health mobile outreach exhibit --California's only traveling health exhibit for children ages 5 and under.
Apr 3, 2008 - 1:36:02 PM
Non-Public Companies
:
Healthcare/BioTech
Best of Show Award Winners Named at the Fifteenth International Molecular Medicine Tri-Conference
NEEDHAM, MA -- (MARKET WIRE) -- 04/03/08 -- Cambridge Healthtech Institute (CHI) announceswinners from Best of Show - New Product competition held at last week'sMolecular Medicine Tri-Conference at the Moscone North Convention Center inSan Francisco, CA.
Apr 3, 2008 - 1:36:02 PM
Non-Public Companies
:
Healthcare/BioTech
Cambridge Healthtech Institute Acquires Barnett International From PAREXEL International
NEEDHAM, MA -- (MARKET WIRE) -- 04/03/08 -- Cambridge Healthtech Institute (CHI) ofNeedham, MA today announced the acquisition of Barnett International fromPAREXEL International. Barnett is recognized as a leader in clinicaleducation and training resources. This acquisition expands CHI's productportfolio to include Barnett's expansive list of seminars, webinars,training consulting and publications. In addition, CHI and Barnett willserve as publisher and distributor for PAREXEL's list of publications inthe clinical and regulatory segment, including PAREXEL's Bio/PharmaceuticalR&D Statistical Sourcebook.
Apr 3, 2008 - 8:36:01 AM
Non-Public Companies
:
Healthcare/BioTech
BDC Venture Capital and GO Capital Invest in Alethia Biotherapeutics, a Montreal Biotechnology Firm
MONTREAL, QUEBEC -- (MARKET WIRE) -- 04/03/08 -- Alethia Biotherapeutics announces that it has secured C$2.4 M in financing from BDC Venture Capital and GO Capital Fund. This investment will allow Alethia to initiate the pre-clinical development of therapeutic monoclonal antibodies for the treatment and prevention of severe bone loss, ovarian cancer, and metastatic breast cancer, indications for which there are currently few therapeutic options.
Apr 3, 2008 - 7:36:02 AM
Non-Public Companies
:
Healthcare/BioTech
Medical Affairs Globalization: Sound Management Strategy, or Passing Trend?
RESEARCH TRIANGLE PARK, NC -- (MARKET WIRE) -- 04/03/08 -- Many pharmaceutical companiesnow command a global presence, which has triggered some organizations toglobalize their medical affairs departments. However, as a study byCutting Edge Information has found, individual companies must weigh theadvantages and disadvantages of globalizing medical affairs to determine ifit is a sound structural model for their organization(www.pharmamedicalaffairs.com).
Apr 3, 2008 - 6:36:01 AM
Non-Public Companies
:
Healthcare/BioTech
White Paper Offers Physician's Perspective on Rural Medicine
ALPHARETTA, GA -- (MARKET WIRE) -- 04/02/08 -- A white paper now available from recruitingfirm LocumTenens.com throughHealthLeaders Media (http://www.healthleadersmedia.com/) offers thephysician's perspective on practicing rural medicine in the context ofsecondary rural health care data from the federal government and othersources.
Apr 2, 2008 - 7:36:01 AM
Non-Public Companies
:
Healthcare/BioTech
New Study From Cutting Edge Information Reveals That Regulations Are Considered Top Challenge for Investigator-Initiated Trials Departments
RESEARCH TRIANGLE PARK, NC -- (MARKET WIRE) -- 04/02/08 -- A new study released by CuttingEdge Information finds that the biggest challenge facing organizations intheir investigator-initiated trials (IITs) is the investigators' lack offamiliarity with the regulatory process. 38% of companies claim thatunderstanding the complexity of regulations regarding trials led by outsideinvestigators -- and imparting that knowledge to the investigators -- istheir most crucial concern. CEI's report, "Investigator-Initiated Trials:Building Superior IIT Capabilities," examines IIT strategies, structures,timelines and investments.
Apr 2, 2008 - 6:36:02 AM
Non-Public Companies
:
Healthcare/BioTech
Blood Diagnostics, Inc. (BDI) Breaks Ground on New Corporate Headquarters
COLUMBIA, SC -- (MARKET WIRE) -- 04/01/08 -- Blood Diagnostics, Inc. (BDI), a nationalleader in the distribution of biopharmaceutical products, broke ground onits new corporate headquarters in March of this year. The facility islocated in the Carolina Research Park in Columbia, South Carolina. The newconstruction is designed to reflect the company's culture and featuresstate-of-the-art warehouse design and management, large capacity trainingfacilities and advanced communication capabilities. BDI announced inOctober that it would relocate its headquarters to a larger facility toaccommodate the company's growth.
Apr 1, 2008 - 3:36:01 PM
Non-Public Companies
:
Healthcare/BioTech
Impacts of BARDA and DOD's Plan on Biodefense Countermeasures to Be Hot Topic at 6th Annual Biodefense Vaccines & Therapeutics Conference
LOS ANGELES, CA -- (MARKET WIRE) -- 04/01/08 -- Special Assistant to the President forBiodefense and Senior Director for Biological Defense Policy Robert Kadlecwill give the Keynote Address on government efforts to accelerate thedevelopment of biodefense and pandemic influenza medical countermeasures atInfocast 6th annual Biodefense Vaccines & Therapeutics Conference,scheduled for June 9-11, 2008 in Washington, DC.
Apr 1, 2008 - 1:36:01 PM
|
|
|
|
